title: [Effect of the pharmacological antagonism of the endocannabinoid receptors on the sodium balance in liver cirrhosis].
abstract: The endocannabinoids are endogenous mediators implicated in many physiologic and pathophysiologic processes. It has been recently shown that they contribute to the pathogenesis of liver fibrosis and hemodynamic alterations of cirrhosis. The pharmacological modulation of the endocannnabinoid system represents a potential target for the treatment of liver diseases.
authors.affiliation: Dipartimento di Medicina Clinica, U.O. Semeiotica Medica, Alma Mater Studiorum Università di Bologna.
authors.forename: Giancarlo
authors.initials: G
authors.lastname: Montanari
authors.forename: Luca
authors.initials: L
authors.lastname: Santi
authors.forename: Ferdinando
authors.initials: F
authors.lastname: Giannone
authors.forename: Mario Luca
authors.initials: ML
authors.lastname: Morieri
authors.forename: Marco
authors.initials: M
authors.lastname: Domenicali
authors.forename: Paolo
authors.initials: P
authors.lastname: Caraceni
authors.forename: Mauro
authors.initials: M
authors.lastname: Bernardi
mesh_terms: D063387:Cannabinoid Receptor Antagonists; D006439:Hemodynamics; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications / Q000378:metabolism* / Q000503:physiopathology; D012964:Sodium / Q000378:metabolism*; D014883:Water-Electrolyte Imbalance / Q000150:complications
chemical_list: D063387:Cannabinoid Receptor Antagonists; D012964:Sodium